课题基金 / 基金详情

AMINOTHIOL THERAPY IN NEPHROPATHIC CYSTINOSIS

AMINOTHIOL THERAPY IN NEPHROPATHIC CYSTINOSIS
氨基硫醇治疗肾病性胱氨酸贮积症
批准号:
6244626
负责人:
JESS G THOENE
金额:
$2.22万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-02-20 至 1997-11-30

项目摘要

项目成果

JESS G THOENE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cysteamine therapy of nephropathic cystinosis received new drug approval from the FDA on August 15, 1994. The clinical investigation leading to new drug approval was initiated by Dr. Thoene at the University of Michigan in 1978. At this time the above referenced protocol is maintained to assist those children who cannot tolerate the marketed version which is prepared only in 50 mg and 200 mg capsules.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TK019: A Study of Replagal Enzyme Replacement Therapy
  • 批准号:
    7044000
  • 项目类别:
  • 资助金额:
    $0.3万
  • 财政年份:
    2003
  • 负责人:
    JESS G THOENE
  • 依托单位:
NTBC THERAPY OF TYROSINEMIA TYPE I
AMINOTHIOL THERAPY IN NEPHROPATHIC CYSTINOSIS
NTBC THERAPY OF TYROSINEMIA TYPE I
海外基金